Eli Lilly & Co. (LLY)
1027.51
+18.13
(+1.80%)
USD |
NYSE |
Dec 12, 16:00
1029.21
+1.70
(+0.17%)
After-Hours: 20:00
Eli Lilly Research and Development Expense (Annual): 10.99B for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Amgen, Inc. | 5.676B |
| Regeneron Pharmaceuticals, Inc. | 4.624B |
| Adverum Biotechnologies, Inc. | 77.04M |
| Viking Therapeutics, Inc. | 101.64M |
| Moderna, Inc. | 4.354B |